It’s past time that we put a stop to skyrocketing prescription drug prices that are devastating hardworking American families, and there is no reason Americans should be forced to pay far more than people in other countries for the same medication.
Continue lowering prescription drug prices through negotiated lower prices.
Occurrences
Evidence
“On January 1, 2026, new negotiated maximum fair prices under the Medicare Drug Price Negotiation Program went into effect and the Medicare Transaction Facilitator (MTF) began operations to support drug manufacturers in effectuating these new negotiated maximum fair prices.”
“Eligible individuals enrolled in Medicare Part D prescription drug plans will be able to access these medications at a predictable and affordable cost—$50 for a monthly supply.”
Assessments
The promised outcome was to continue lowering prescription drug prices through negotiated lower prices. The Medicare Drug Price Negotiation Program’s negotiated maximum fair prices went into effect on January 1, 2026, during Foster’s current federal House term, and CMS infrastructure is operating to implement those prices. Because Foster is an active federal representative and the evidence shows the negotiated lower-price policy taking effect during his term, this counts as delivered rather than merely attempted. The additional CMS drug-pricing demonstration supports continued federal action but is not necessary to establish delivery.